Brief: ALK-Abelló partner submits NDA application for HDM SLIT-tablet in Japan

Torii Pharmaceutical Co

26/01/2015 08:00

Jan 26 (Reuters) - ALK Abello A/S  ALKb.CO : 
    * Says the company's partner for Japan, Torii Pharmaceutical 
Co. Ltd, submits registration application for house dust mite 
(HDM) sublingual allergy immunotherapy tablet (SLIT) in Japan 
    * Torii has submitted the new drug application (NDA) to 
Japanese Ministry of Health, Labour and Welfare (MHLW) 
    * Intends to conduct further clinical trials with HDM 
SLIT-tablet to allow access to China and other emerging markets 
 
Source text for Eikon:  ID:nGNXVCOVVa  
Further company coverage:  ALKb.CO  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;)) 
 
Keywords: ALK ABELLO/BRIEF